Zoono Group Limited (AU:ZNO) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Zoono Group Limited, a global biotech company specializing in long-lasting antimicrobial solutions, reported a significant downturn in its financial results, with revenues plummeting by 68.6% to NZ$1,049,321 and a striking increase in losses to NZ$9,185,193 for the fiscal year ended June 30, 2024. The company, known for its innovative ‘ZOONO molecule’ products, has decided not to pay a dividend for 2024, reflecting its challenging financial performance.
For further insights into AU:ZNO stock, check out TipRanks’ Stock Analysis page.